Guardian Point Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Guardian Point Capital’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$7.16M	–	18
2016 Q1	$7.16M	Sell	50,000 -20,000	-29%	-$2.84M	6.11%	7
2015 Q4	$10.8M	Buy	+70,000	New	+$10.2M	10.19%	3

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Guardian Point Capital's TARO Position: Q2 2016 in Review

Guardian Point Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 50,000 shares — an estimated $7.16M sold.

Guardian Point Capital first reported a position in TARO in Q4 2015 and held it in 2 quarters. The position peaked at $10.8M in Q4 2015. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Guardian Point Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Guardian Point Capital sold 50,000 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $7.16M.
Guardian Point Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 2 quarters.
Guardian Point Capital's Taro Pharmaceutical Industries Ltd. position peaked at $10.8M in Q4 2015.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Guardian Point Capital's 13F filing for Q2 2016, filed 15 Aug 2016.